July 24 (Reuters) - Biogen (BIIB.O), opens new tab and Sage Therapeutics (SAGE.O), opens new tab do not plan to conduct further studies for their neurological disorder drug after it failed in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback